BCV
IRMD icon

Banque Cantonale Vaudoise’s iRadimed IRMD Stock Holding History

Banque Cantonale Vaudoise’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-200
Closed -$9K – 1316
2022
Q1 		$9K Hold
200
– – ﹤0.01% 1215
2021
Q4 		$9K Hold
200
– – ﹤0.01% 1244
2021
Q3 		$7K Buy
+200
New +$6.8K ﹤0.01% 1230

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Banque Cantonale Vaudoise's IRMD Position: Q2 2022 in Review

Banque Cantonale Vaudoise sold out of iRadimed (IRMD) in Q2 2022, closing a stake of 200 shares — an estimated $9K sold.

Banque Cantonale Vaudoise first reported a position in IRMD in Q3 2021 and held it in 3 quarters. The position peaked at $9K in Q1 2022. 90 funds tracked by Wall St. Rank hold IRMD as of Q2 2022.

  • Banque Cantonale Vaudoise reported no remaining iRadimed position as of Q2 2022 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 200 iRadimed shares in Q2 2022, an estimated $9K.
  • Banque Cantonale Vaudoise first reported a position in iRadimed in Q3 2021 and held it in 3 quarters.
  • Banque Cantonale Vaudoise's iRadimed position peaked at $9K in Q1 2022.
  • 90 funds tracked by Wall St. Rank held iRadimed as of Q2 2022.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2022, filed 2 Aug 2022.